AERIE PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2022.
  • Aerie Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 47.8M shares, a 3.19% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.3M shares, a 0.96% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 45.9M shares, a 1.04% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 47.8M +1.48M +3.19% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 47.6M +1.37M +2.96% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 47.5M +1.41M +3.06% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 46.3M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-25
Q3 2021 46.3M +397K +0.86% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 46.2M +322K +0.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 46.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 45.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 45.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.